Despite earlier concerns, dieters who repeatedly lose weight and then gain it back aren’t at higher risk of early death than people who don’t “yo-yo diet”….
Read More »Psychology in Diabetes Care, 2nd Ed, Part 14
Edited by Frank J. Snoek and T. Chas Skinner Diabetes in Older Adults 4.1 Introduction Diabetes mellitus is a common metabolic disorder affecting older adults.
Read More »Diabetes Mellitus 101 for Medical Professionals, Part 6 of 9
In this week’s Homerun Slides, we present Part 6 of Dr. Stanley Schwartz’s series on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes, in which we will look closely at at "Modern Insulin Resistant Man" who is locked into "Seasonal Insulin Resistance Syndrome Physiology"….
Read More »Nike Fuel Band: Tracks All Physical Activities
Nike Fuel Band: Tracks All Physical Activities Nike has unveiled the Nike+ FuelBand, a product that fits around your wrist and aims to provide a common metric for tracking all physical activities. The FuelBand tracks what the company calls NikeFuel, which lets people compare a game of basketball to a …
Read More »Bydureon Mixing Instructions
The mixing of the Bydureon weekly injection may be confusing for some, so we are providing you with some of the information distributed in Europe. Click here for the Bydureon Mixing Instructions (pdf) For a complete list of all of our popular Tools for Your Practice, just follow this link.
Read More »Gene Study Sheds Light on Body Clock’s Link to Diabetes
A mutation affecting a sleep-wake hormone may disrupt blood sugar control.…
Read More »Effect of Sitagliptin on Serum Total Ghrelin Levels in Type 2’s
In this study of patients with type 2 diabetes, treatment with sitagliptin was associated with a significant decrease in serum ghrelin levels….
Read More »FDA Approves Eli Lilly Diabetes Combo Drug Jentadueto
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company announced the FDA approved Jentadueto™ (linagliptin/metformin hydrochloride) tablets….
Read More »Metformin May Help Protect Women against Pancreatic Cancer
A new study links the diabetes drug metformin to fewer cases of pancreatic cancer — at least in women — but finds other diabetes medications are associated with a higher risk of the disease.…
Read More »Risks of Tight BP Control May Outweigh Benefits
In diabetes patients, the stroke-preventing benefits of bringing systolic blood pressure below 130 mmHg may be offset by an increased risk of cardiac events.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.